Related Experiment Video

Updated: May 3, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
09:09

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

Published on: March 14, 2019

9.0K

Comparison of the Effectiveness of Ceftobiprole and Vancomycin in a Rabbit Model of Methicillin-Resistant

Sinan Mermer1,2, Tuncer Turhan3, Elif Bolat3

  • 1Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.

Chemotherapy
|May 2, 2024
PubMed
Abstract

Insights

Ceftobiprole and vancomycin showed equal effectiveness in treating methicillin-resistant Staphylococcus aureus (MRSA) meningitis in a rabbit model. Both treatments significantly reduced bacterial levels and improved survival compared to controls.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Nosocomial meningitis can arise from central nervous system procedures or trauma.
  • Staphylococcus aureus is a common causative agent of bacterial meningitis.
  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant treatment challenge.

Purpose of the Study:

  • To compare the efficacy of ceftobiprole and vancomycin against MRSA meningitis.
  • To evaluate treatment effectiveness in a relevant animal model.

Main Methods:

  • An animal model of MRSA meningitis was established using ATCC 43300 strain.
  • Animals received either ceftobiprole (25 mg/kg), vancomycin (20 mg/kg), or no treatment (control).
  • Cerebrospinal fluid (CSF) bacterial levels and survival rates were assessed over 73 hours.

Main Results:

  • Both ceftobiprole and vancomycin significantly reduced CSF bacterial levels compared to controls at 24 and 73 hours.
  • Survival rates were significantly higher in both treatment groups versus the control group.
  • No significant difference in survival was observed between ceftobiprole and vancomycin treated animals.

Conclusions:

  • Ceftobiprole and vancomycin demonstrate comparable efficacy in treating MRSA meningitis in this rabbit model.
  • Intravenous administration of both agents provides a viable therapeutic option.
Keywords:
Animal modelCeftobiproleNosocomial meningitisPharmacokineticsVancomycin

More Related Videos

In Vivo Mouse Model of Spinal Implant Infection08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.3K
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.0K

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
259
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24